Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy
2012 · Journal of Ophthalmic Inflammation and Infection · 48 citations
https://doi.org/10.1007/s12348-012-0067-9
Y
Yevgeniy Shildkrot
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
704
Citations
17
h-index
20
i10-index
Yevgeniy Shildkrot is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Ocular Oncology and Treatments & Glaucoma and retinal disorders & Retinal and Macular Surgery. The author has an h-index of 17, co-authored 52 publications.
Papers by this author
worksPrimary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema
2019 · International Journal of Retina and Vitreous · 21 citations
https://doi.org/10.1186/s40942-019-0178-7
Multiple evanescent white dot syndrome-like reaction associated with ipilimumab and nivolumab immune checkpoint inhibitor therapy for metastasis of choroidal melanoma
2022 · American Journal of Ophthalmology Case Reports · 7 citations
https://doi.org/10.1016/j.ajoc.2022.101351
Supplementary Material for: Gene Expression Profiling in Uveal Melanoma: Five-Year Prospective Outcomes and Meta-Analysis
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12612824
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat